Physician profile
Patrick David Devanny
NPI 1902881931
$2,673.81
in general payments reported to CMS, 2019-2025
10 companies · $34.69 in 2025
The $34.69 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.94 · 2021: $151 · 2022: $45.21 · 2023: $1,443 · 2024: $987 · 2025: $34.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,394 · Food and Beverage: $70.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,394.19 |
| Food and Beverage | $70.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fx Shoulder Solutions, INC | $1,435.25 | 2023 | |
| Shoulder Innovations, INC. | $958.94 | 2024 | Inset System |
| Stryker Corporation | $139.37 | 2021 | |
| Axogen | $45.21 | 2022 | |
| Zimmer Biomet Holdings, INC. | $27.93 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.89 | 2025 | Entyvio |
| Biowound Solutions, INC. | $16.80 | 2025 | Bio-Connekt |
| Endo Pharmaceuticals INC. | $12.94 | 2019 | |
| Abbvie INC. | $11.26 | 2021 | |
| Sonex Health, INC. | $8.22 | 2023 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Devanny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.